Appointments
All Deals
Declared | Dealt | Type | EPIC | Company | Director | Pos | Shares | Price | Value | Cur. price | % Gain | Gain |
---|---|---|---|---|---|---|---|---|---|---|---|---|
24/02/21 | 22/02/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 438 | $17.22 | $7,542 | 1,204.00p | ||
24/02/21 | 22/02/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,446 | $17.22 | $42,120 | 1,204.00p | ||
22/02/21 | 18/02/21 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 142 | $17.35 | $2,464 | 1,204.00p | ||
22/02/21 | 18/02/21 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 5,662 | $17.35 | $98,236 | 1,204.00p | ||
17/02/21 | 12/02/21 | SELL | GSK | Glaxosmithkline PLC | Hal Barron | ED | 173,710 | $17.85 | $3,100,532 | 1,204.00p | ||
15/02/21 | 11/02/21 | TIN | GSK | Glaxosmithkline PLC | Hal Barron | ED | 180,833 | $0.00 | $0 | 1,204.00p | ||
10/02/21 | 08/02/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 424 | $17.73 | $7,518 | 1,204.00p | ||
10/02/21 | 08/02/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,376 | $17.73 | $42,126 | 1,204.00p | ||
26/01/21 | 22/01/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 392 | $19.18 | $7,519 | 1,204.00p | ||
26/01/21 | 22/01/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,196 | $19.18 | $42,119 | 1,204.00p | ||
20/01/21 | 18/01/21 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 846 | $19.08 | $16,142 | 1,204.00p | ||
20/01/21 | 18/01/21 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 1,078 | $19.08 | $20,568 | 1,204.00p | ||
11/01/21 | 07/01/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,170 | $19.04 | $41,306 | 1,204.00p | ||
11/01/21 | 07/01/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 388 | $19.04 | $7,386 | 1,204.00p | ||
23/12/20 | 21/12/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,301 | $18.11 | $41,671 | 1,204.00p | ||
09/12/20 | 07/12/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,218 | $18.78 | $41,654 | 1,204.00p | ||
25/11/20 | 23/11/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,269 | $18.37 | $41,682 | 1,204.00p | ||
17/11/20 | 12/11/20 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 3,872 | $18.88 | $73,084 | 1,204.00p | ||
17/11/20 | 12/11/20 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 86 | $18.88 | $1,623 | 1,204.00p | ||
11/11/20 | 09/11/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,223 | $18.75 | $41,670 | 1,204.00p |
Transaction types:
- BUY - Buy
- SELL - Sell
- EXR - Exercise
- SEXR - Sale Post-Exercise
- DRI - Dividend Reinvestment
- DRIP - Dividend Reinvestment Plan
- AWD - Award
- TIN - Transfer In
- TOUT - Transfer Out
- LOF - In Lieu of Fees/Salary
- SI - Scrip Issue
- PLAC - Placing
- RIS - Rights Issue
Director positions:
- CEO - Chief Executive Officer
- CH - Chairman
- MD - Managing Director
- FD - Financial Director
- NED - Non Executive Director
- ED - Executive Director
- RES - Resigned
- D - Director / Unknown